1Piver MS,Lele SB,Marchetti DL,et al.The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage Ⅲ and Ⅳ ovarian carcinoma.J Clin Oncol,1998,6 (6):983-989
2Eisenkop SM,Friedman RL,Spirtos NM,et al.The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma.Cancer,2000,88 (1):144-153
3Goodman HM,Hardlow BL,Sheet EE et al.The role of cytoreductive surgery in the management of stage Ⅳ epithelial ovarian carcinoma.Gynecol Oncol,1992,46(3):367-371
4Liu PC,BenjaminⅠ,MorganMa,et al.Effect of surgical debulking on survial in stage Ⅳ ovrian cancer.Gynecol Oncol,1997,64(1):4-8
6Munkarrah AR,Hallum AV,Morris M,et al.Prognostic significance of residual disease in patients with stage Ⅳ epithelial ovarithelial ovarian cancer.Gynecol Oncol,1997,64(1):13-17
7Bristow RE,Montz FJ,Cagasee LD,et al.Survival impact of surgieal cytoreduction in stage Ⅳ epithelial ovarian cancer.Gynecol Oncol,1999,72(3):278-287
8Scarabelli C,Gallo A,Franceschi S,et al.Primary Cytoreductive surgery with rectosigmoid colon for patients with advanced epithelial ovarian carcinoma.Cancer,2000,88(2):389-397
9Suzuki M,Tsukagoshi S,Ohwada M,et al.A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment.Gynecol Oncol,1999,74(3):483-486
